首页|阿仑膦酸钠联合化疗对多发性骨髓瘤患者骨代谢的影响

阿仑膦酸钠联合化疗对多发性骨髓瘤患者骨代谢的影响

The Effects of Alendronate Combined with Chemotherapy on Bone Metabolism in Patients with Multiple Myeloma

扫码查看
目的:探讨阿仑膦酸钠联合化疗对多发性骨髓瘤(MM)患者骨代谢的影响.方法:以MM患者为研究对象,随机分成试验组和对照组.试验组在化疗基础上给予阿仑膦酸钠片治疗;而仅给予化疗者作为对照组.比较两组骨特异性碱性磷酸酶(BAP)、I型前胶原氨基肽(PⅠNP)、骨钙素(OC)、β胶原特殊序列(β-CTx)、血钙、血磷及碱性磷酸酶的差别.结果:试验组治疗后BAP、PⅠNP和OC显著高于治疗前和对照组治疗后,差异均有统计学意义(P<0.01);试验组治疗后β-CTx显著低于治疗前和对照组治疗后,差异有统计学意义(P<0.01);对照组各骨代谢相关指标比较,差异无统计学意义(P>0.05).结论:阿仑膦酸钠联合化疗可有效改善MM患者的骨代谢.
Objective To explore the effects of alendronate combined with chemotherapy on bone metabolism in patients with multiple myeloma( MM). Methods Randomized the patients accepted treatment of alendionate combined with chemotherapy were divided into the observe group. Besides, the patients accepted only chemotherapy served as control group. The differences of the bone alkaline phosphotase(BAP) , procollagen Ⅰ N-tenninal propeptide(P Ⅰ NP) , steocalein(OC) , β-crosslaps(β-CTx) .calcium, phosphorus and allralinn phosphatase were compared between the two group. Results After treatment, the concentrations of BAP, P I NP and OC in the observed group presented significantly higher than those in the control group(P <0.05) ; but the concentration of β-CTx in the observed group showed obviously lower than the control group(P<0.05) ; there's no significant difference of bone metabolism befoere and after treatment in the control group (P > 0. 05). Conclusion Alendronate combined with chemotherapy possess good effect for improvement of bone metabolism in patients with MM.

alendronatemultiple myeloma(MM)bone metabolism

刘泰然、叶舒婷

展开 >

浙江省温岭市第一人民医院血液内科,317500

阿仑膦酸钠 多发性骨髓瘤 骨代谢

2013

放射免疫学杂志
同济大学

放射免疫学杂志

CSTPCD
影响因子:0.508
ISSN:1008-9810
年,卷(期):2013.26(4)
  • 5
  • 4